Oncotarget is an open-access journal that is published by Impact Journal. It was started in 2010 and is released online weekly. It mostly publishes papers on oncology. Its mission is to ensure that all diseases are eradicated. The journal is indexed in the Science Citation Index Expanded, Scopus, Index Medicus, and PubMed. Oncotarget is ranked highly among medical journals, especially those that are open-access. The journal has averaged an impact factor of 5.0 for the past five years. Its success can be attributed to the professionalism and expertise of the editors and the members of the editorial board.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/
Mikhail Blagosklonny and Andrei Gudkov are the editors-in-chief of Oncotarget. Both of them work at the Roswell Park Cancer Institute. They are recognized authorities in medical research. Gudkov is a senior vice president of medical research and a professor at the Institute. Blagosklonny is an oncology professor. His papers have appeared in peer-reviewed journals. Mikhail has written more than 200 papers. They have been cited very many times.
Its editorial board comprises of respected scholars and researchers who have won numerous accolades including the Lasker Prize and the Breakthrough Prize. The Journal funds and sponsors multiple events that are held in various locations around the world. It was recently a sponsor of the sixth Gordon Research Conference that was held in Italy. The conference took place in February. The topics discussed revolved around stem cells and aging.
Oncotarget accepts papers on several other fields that relate to oncology including neuroscience, aging, endocrinology, and cell biology. The editors decided to go forward with this change so that other fields could capitalize on the success of Oncotarget. Oncotarget makes it easier for medical findings to be accessed by anyone from around the world because it is free and is released online. The medical journal has also improved the medical research field by increasing the rate that papers are published.
Oncotarget has removed the barriers between different fields by bringing researchers together by accepting papers from multiple fields. This has resulted in cross-border collaborations that would not have been possible. Oncotarget is also available on Dove Press.